US20110029073A1 - Methods and Devices for Refractive Corrections of Presbyopia - Google Patents

Methods and Devices for Refractive Corrections of Presbyopia Download PDF

Info

Publication number
US20110029073A1
US20110029073A1 US12/935,287 US93528709A US2011029073A1 US 20110029073 A1 US20110029073 A1 US 20110029073A1 US 93528709 A US93528709 A US 93528709A US 2011029073 A1 US2011029073 A1 US 2011029073A1
Authority
US
United States
Prior art keywords
eye
refractive power
lens
spherical aberration
spherical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/935,287
Inventor
Junzhong Liang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/935,287 priority Critical patent/US20110029073A1/en
Publication of US20110029073A1 publication Critical patent/US20110029073A1/en
Assigned to SIFI S.P.A. reassignment SIFI S.P.A. LICENSE (SEE DOCUMENT FOR DETAILS). Assignors: LIANG, JUNZHONG
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/147Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/145Corneal inlays, onlays, or lenses for refractive correction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1637Correcting aberrations caused by inhomogeneities; correcting intrinsic aberrations, e.g. of the cornea, of the surface of the natural lens, aspheric, cylindrical, toric lenses
    • A61F2/164Aspheric lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1648Multipart lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F9/00802Methods or devices for eye surgery using laser for photoablation
    • A61F9/00804Refractive treatments
    • A61F9/00808Inducing higher orders, e.g. for correction of presbyopia
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/024Methods of designing ophthalmic lenses
    • G02C7/028Special mathematical design techniques
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04Contact lenses for the eyes
    • G02C7/041Contact lenses for the eyes bifocal; multifocal
    • G02C7/042Simultaneous type
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04Contact lenses for the eyes
    • G02C7/041Contact lenses for the eyes bifocal; multifocal
    • G02C7/044Annular configuration, e.g. pupil tuned
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/06Lenses; Lens systems ; Methods of designing lenses bifocal; multifocal ; progressive
    • G02C7/061Spectacle lenses with progressively varying focal power
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1616Pseudo-accommodative, e.g. multifocal or enabling monovision
    • A61F2/1618Multifocal lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1637Correcting aberrations caused by inhomogeneities; correcting intrinsic aberrations, e.g. of the cornea, of the surface of the natural lens, aspheric, cylindrical, toric lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1637Correcting aberrations caused by inhomogeneities; correcting intrinsic aberrations, e.g. of the cornea, of the surface of the natural lens, aspheric, cylindrical, toric lenses
    • A61F2/1643Cylindrical lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F2009/00861Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00872Cornea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F2009/00878Planning
    • A61F2009/0088Planning based on wavefront
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F9/00802Methods or devices for eye surgery using laser for photoablation
    • A61F9/00812Inlays; Onlays; Intraocular lenses [IOL]

Definitions

  • the field of the invention relates to refractive correction of human eyes, in particular, for refractive treatments of presbyopia.
  • Presbyopia is an age-related problem with near vision, due to progressive reduction in the eye's ability to focus, with consequent difficulty in reading at the normal distance.
  • An effective refractive correction of presbyopia must provide focus for far, intermediate, and near vision in all conditions of pupil size.
  • p Diffractive intraocular lenses (IOLs) such as those described in U.S. Pat. No. 5,116,111 by Michael Simpson and John Futhey and in US 2006/0116764A1 by Michael Simpson can provide simultaneous bi-focus (far vision and near vision) correction for presbyopia, but have two inherent disadvantages: Degraded night vision with night glare caused by light scattering at the junctions of diffractive zones in the lens surface, and a blind spot at intermediate distance between the far and near focus points.
  • Multifocal designs by controlling light distribution for far, intermediate, and near vision across different aperture size of a lens were proposed by Valdmar Portney in U.S. Pat. Nos. 5,225,858 and 6,557,998B2. These lens designs can perform better for intermediate vision than Simpson's diffractive IOLs, but are also known to be inferior for performance at near vision. Moreover, Portney's lenses fail to achieve their full potential as they are based on simple geometric ray tracing, without taking into account a diffraction effect of light propagation.
  • Aspheric lenses were also proposed in U.S. Pat. No. 6,923,539B2 by Michael Simpson and in U.S. Pat. Nos. 5,166,711 and 6,409,340B1 by Valdmar Portney. These lenses have a periodic refractive power distribution across a lens. While Simpson's lens can increase focus depth for a mono-focal lens as illustrated in FIG. 9 of U.S. Pat. No. 6,923,539B2, such lens is typically not suitable for presbyopic correction.
  • Spherical aberration across the pupil of an eye produces different focusing power at different pupil radii.
  • Negative spherical aberration across pupil of an eye was proposed for mitigation of presbyopia by Seema Somani and Kingman Yee in U.S. Pat. No. 7,261,412 B2.
  • negative spherical aberration across the entire pupil can shift the center of the focus range from far to an intermediate distance because negative spherical aberration produces focus power for far vision at the pupil center to intermediate vision at the pupil periphery.
  • the present inventive subject matter is drawn to methods and devices for refractive treatment of presbyopia.
  • a corneal implant device for surgical implantation between the layers and in the optic zone of a cornea of an eye for treatment of presbyopia comprises a solid transparent optic less than 6.5 mm in diameter, wherein when implanted in the eye spherical aberration or a distribution of spherical aberrations is created in the central pupil between 1.5 mm and 4.0 mm in diameter only by the presence of said device.
  • a procedure for treatment of presbyopia comprises the steps of measuring refractive properties of an eye; removing corneal tissue to create spherical aberration or a distribution of spherical aberrations in the central pupil of an eye less than 4 mm in diameter.
  • a lens for the treatment of presbyopia of an eye comprises an inner optical section of 1.5 mm to 4 mm in diameter that contains at least one aspheric surface to induce spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power; an outer transparent optical section of 4 mm to 40 mm in diameter that is configured to have a dominant spherical focus power.
  • a lens for the treatment of presbyopia of an eye comprises an inner optical section of 1.5 mm to 3.6 mm in diameter, wherein the inner optical section contains at least one aspheric surface to create spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power; an middle optical section with an outer diameter of 2.5 mm to 5 mm that is configured to be a bi-focal lens; and an outer optical section with an outer diameter of 4 mm to 40 mm that is configured to have a dominant focus power.
  • an optical device for refractive treatment of presbyopia comprises an inner transparent optical section that contains at least one aspheric surface to induce spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power; a middle section that is configured to attenuate or block light energy; and an outer transparent optical section that is configured to have a dominant spherical focus power.
  • FIG. 1A shows a front view of an eye's optics that is divided into two optical sections: a central optical zone and an outer optical zone.
  • FIG. 1B shows a wavefront map for a refractive correction of presbyopia in a method of introducing spherical aberration only at a central pupil section of an eye.
  • FIG. 1C shows the radial distribution of refractive power derived from the wavefront map in FIG. 1B .
  • FIG. 1D shows a wavefront map for a refractive correction of presbyopia in a method of introducing a distribution of spherical aberrations only at a central pupil section of an eye.
  • FIG. 1E shows the radial distribution of a refractive power derived from the wavefront map in FIG. 1D .
  • FIG. 2 shows the calculated MTFs (modulation transfer functions) of an eye with a wavefront map specified in FIG. 1B for three pupil sizes and at 3 different focus positions.
  • FIG. 3 shows the calculated MTFs of an eye with a wavefront map specified in FIG. 1D for three pupil sizes and at 4 different focus positions.
  • FIG. 4A shows a schematic diagram of a refractive element to be implanted into an eye for refractive corrections of presbyopia.
  • FIG. 4B shows a radial distribution of refractive power for the refractive element in FIG. 4A in one embodiment.
  • FIG. 4C shows a radial distribution of refractive power for the refractive element in FIG. 4A in another embodiment.
  • FIG. 4D shows a radial distribution of refractive power for the refractive element in FIG. 4A in yet another embodiment.
  • FIG. 4E shows schematic diagrams of a refractive element that can be worn on or implanted into an eye for refractive correction of presbyopia.
  • FIG. 4F shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a gradually increased refractive power in the central optical section and a constant refractive power beyond the central optical section.
  • FIG. 4G shows a radial distribution of refractive power for the refractive element in FIG. 4E in an embodiment that has a gradually increased refractive power in the central optical section and a custom focus offset, depending on spherical aberration in an individual eye, beyond the central optical section.
  • FIG. 4H shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a gradually increased refractive power in the central optical section and a different radial distribution of refractive power beyond the central optical section.
  • FIG. 4I shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a gradually reduced refractive power in the central optical section and a constant refractive power beyond the central optical section.
  • FIG. 4J shows a radial distribution of refractive power for the refractive element in FIG. 4E in an embodiment that has a gradually reduced refractive power in the central optical section and a custom focus offset, depending on spherical aberration in an individual eye, beyond the central optical section.
  • FIG. 4K shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a gradually reduced refractive power in the central optical section and a different radial distribution of refractive power beyond the central optical section.
  • FIG. 4L shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a first zone of reduced refractive power and a second zone of increased refractive power in the central optical section, and a constant refractive power beyond the central optical section.
  • FIG. 4M shows a radial distribution of refractive power for the refractive element in FIG. 4E in an embodiment that has a zone of reduced refractive power and a zone of increased refractive power in the central optical section, and a custom focus offset, depending on spherical aberration in an individual eye, beyond the central optical section.
  • FIG. 4N shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a zone of reduced refractive power and another zone of increased refractive power in the central optical section, and a different radial distribution of refractive power beyond the central optical section.
  • FIG. 5A shows a schematic diagram of a refractive element to be worn on or implanted in an eye for refractive correction of presbyopia.
  • FIG. 5B shows a schematic diagram of another refractive element to be worn on or implanted in an eye for refractive correction of presbyopia.
  • FIG. 5C shows a radial distribution of refractive power for a refractive element in FIG. 5B in one embodiment.
  • FIG. 6A shows a schematic diagram of yet another refractive element to be worn on or implanted in an eye for refractive correction of presbyopia.
  • FIG. 6B shows a schematic diagram of an additional refractive element to be worn on or implanted in an eye for refractive correction of presbyopia.
  • FIG. 7A shows a schematic diagram of a refractive element that can be worn on or implanted into an eye for refractive correction of presbyopia.
  • FIG. 7B shows a side view of the refractive element in FIG. 7A that can be worn on or implanted into an eye for refractive correction of presbyopia.
  • FIG. 7C shows a radial distribution of refractive power for the refractive element in FIG. 7A in one embodiment.
  • FIG. 7D shows a radial distribution of refractive power for the refractive element in FIG. 7A in another embodiment.
  • FIG. 7E shows a radial distribution of refractive power for the refractive element in FIG. 7A in yet another embodiment.
  • the refractive elements described in the present invention may include a baseline refractive correction of conventional refractive errors like myopia, hyperopia and astigmatism.
  • the disclosed shapes only include the added wavefront map or refractive powers beyond the baseline correction for increasing focus depth from far vision to near vision.
  • FIG. 1A shows a schematic diagram of an eye's optics that is divided into two optical sections: the central optical section 10 less than 4.5 mm in diameter and the periphery pupil section 11 up to 8 mm in diameter.
  • the dotted circle in FIG. 1A indicates the iris (pupil) of an eye at night. Diameter of an eye's pupil at night is different from eye to eye, and is smaller for aged eyes than for young eyes (typically 4 mm and 8 mm for night vision).
  • the central optical section less than 4.5 mm in diameter it is well known that spherical aberration in normal human eyes is negligible.
  • We describe methods for refractive correction of presbyopia by introducing positive/negative spherical aberration or a distribution of spherical aberrations only at the central pupil of an eye lens less than 4.5 mm in diameter.
  • a negative (or positive) spherical aberration is introduced in the central optical section of an eye less than 4.5 mm in diameter only.
  • FIG. 1B shows a wavefront map within a 6 mm zone.
  • the wavefront shape, a negative spherical aberration of 4 microns within a diameter of 2.8 mm, can be expressed by Zernike polynomials as ⁇ 0.3 (Z12(r)+3.87*Z4(r)). Beyond the central 2.8 mm zone, the wavefront is constant because no spherical aberration will be introduced.
  • FIG. 1C shows the radial distribution of refractive power derived from the wavefront map in FIG. 1B . It is seen that the introduced negative spherical aberration increases ( 12 ) the refractive power from zero Diopters from pupil center to 8.2 Diopters at radius of 1.4 mm. Beyond the central zone, the refractive power is constant ( 13 ; zero in reference to a baseline refractive power). It must be emphasized that a baseline refractive correction of myopia, hyperopia or astigmatism can be superimposed to the refractive power shown in FIG IC for eyes with conventional refractive errors.
  • the circular section of 1.6 mm has a positive spherical aberration about 1.34 ⁇ m (or 0.1 (Z12(r)+3.87 Z4(r)) and also a focus offset of 4.0 Diopters.
  • the annular section has a fixed focus power (OD) and a negative spherical aberration of about 4.3 ⁇ m (or ⁇ 0.32 (Z12(r)+3.87 Z4(r)).
  • FIG. 1E shows the radial distribution of refractive power derived from the wavefront map in FIG. 1D .
  • the positive spherical aberration in the central 1.6 mm pupil causes a gradually reduced refractive power from the pupil center with a range of about 8 Diopters ( 14 ).
  • the negative spherical aberration in an annual pupil causes a gradually increased refractive power from around 1 Diopter to around 5 Diopters ( 15 ).
  • the wavefront map in FIG. 1D and the refractive power FIG. 1E show the central optical section with spherical aberrations only. Beyond the central 3.6 mm pupil, the wavefront as well as the refractive power is constant, which is not shown for simplicity.
  • FIG. 2 shows the calculated MTFs of a hypothetical eye with a refractive correction specified by the wavefront in FIG. 1B .
  • Three pupil sizes (2 mm, left column; 3.5 mm, middle column; and 6 mm, right column) and 3 distances (far vision at infinity, top; intermediate vision at a focus depth of 1.0 D, middle row; and near vision at a focus depth of 2.0 D, bottom row) are considered.
  • Three important aspects of refractive corrections are noticed. First, the induced spherical aberration in the central pupil won't significantly degrade night vision with a large pupil for distant vision (top row and right column).
  • FIG. 3 shows the calculated MTFs of a hypothetical eye with a refractive correction specified by the wavefront in FIG 1 D. Since increasing spherical aberration at central pupil won't significantly degrade night vision for a large pupil for distance vision as noticed in FIG. 2 , we only calculate MTFs for three pupil sizes within a central 3.6 mm pupil. Three pupil sizes (1.6 mm, left column; 2.6 mm, middle column; and 3.6 mm, right column) and 4 distances (far vision at infinity, top row; intermediate vision at a focus depth of 1.0 D, second row; near vision at a focus depth of 2.0 D, third row; and near vision at a focus depth of 3 D, bottom row) are considered.
  • the wavefront maps in FIG. 1B and FIG. 1D can be obtained by modifying a baseline ablation profile for myopia, hyperopia, and astigmatism.
  • the change in the ablation profile equals to t0 ⁇ W(x,y)/(nc-1), where t0 is a constant thickness, W(x,y) is wavefront map (distribution), and nc is the refractive index of the cornea.
  • Correction using a negative lens in conventional refractive correction must be implemented by removing a positive lens from a corneal for a laser vision correction.
  • the wavefront maps like FIG. 1B and FIG. 1D can be obtained by varying thickness of an inlay according to W(x,y)/(ni-1), where W(x,y) is the desired wavefront map and ni is the refractive index of the corneal inlay.
  • W(x,y) can include a baseline of constant phase delay.
  • the wavefront maps like FIG. 1B and FIG. 1D can be obtained by superimposing the refractive power shown in FIG. 1C and FIG. 1E to a baseline refractive correction or to a constant phase delay across a lens.
  • the wavefront maps like FIG. 1B and FIG. 1D can be obtained by a variation of thickness to the baseline lenses according to W(x,y)/(nL-n0), where W(x,y) is the wavefront map and nL is the refractive index of IOLs or corneal inlay while n0 is the refractive index of cornea or the refractive index of the aqueous humor or vitreous body in the eye.
  • FIG. 4A shows a refractive corneal inlay for refractive correction of presbyopia in accordance with the present invention.
  • the refractive device 40 comprises an optic of a diameter R between 1.5 mm and 4 mm, and has a radial distribution of refractive power in a range more than 4 Diopters across the optic.
  • the lens has the least refractive power in the middle ( ⁇ 1 , and a gradually increased refractive power for an increased radial distance, and a radial power range ( ⁇ 2 - ⁇ 1 ) of more than 4 Diopters and less than 12 Diopters.
  • the lens in FIG. 4A has a diameter of 2.8 mm with a radial distribution of refractive power 41 a same as 12 in FIG. 1B , and ⁇ 1 and ⁇ 2 are 0 Diopter and 8.2 Diopters, respectively.
  • ⁇ 1 and ⁇ 2 are 0 Diopter and 8.2 Diopters, respectively.
  • the lens has the highest refractive power in the middle ( ⁇ 1 ), and a gradually reduced refractive power for an increased radial distance, and a radial power range ( ⁇ 2 - ⁇ 1 ) of more than 4 Diopters and less than 12 Diopters.
  • the lens in FIG. 4A has a diameter of 1.6 mm with a radial distribution of refractive power 41 b same as 14 in FIG. 1E , and ⁇ 1 and ⁇ 2 are 4 Diopter and ⁇ 4.2 Diopters, respectively.
  • the lens has two radial distribution of refractive power: a first zone of reduced refractive power 42 a and a second zone of increased refractive power 42 b.
  • the lens in FIG. 4A has a diameter of 3.6 mm with a radial distribution of refractive power 42 a same as 14 in FIG. 1E , and 42 b same as 15 in FIG. 1E .
  • a lens When such a lens is implanted into the central optics of an eye, it can create a wavefront map like the one shown in FIG. 1D at the central pupil and does not alter refraction of an eye beyond the lens zone.
  • Increasing focus depth of an eye for refractive correction of presbyopia can be seen in FIG. 3 for 3 pupil sizes at 4 different focus positions.
  • a corneal inlay comprises an inner optical section of 1.5 mm to 4 mm in diameter that contains at least one aspheric surface to induce spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power, and an outer transparent optical section of up to 6 mm in diameter.
  • the corneal inlay will have a refractive power extended across the entire corneal inlay for refractive correction of conventional myopia, hyperopia, cylinder error, and any other refractive errors in an eye.
  • the refractive correction with a corneal inlay in FIG. 4A can also be implemented with a procedure of laser vision correction.
  • a procedure of laser vision correction will remove corneal tissues to create a radial distribution of focus power of FIG. 4C and 4E in an opposite sign, superimposed on to a baseline ablation profile for myopia, hyperopia, and astigmatism.
  • a fixed ablation thickness can be added to the ablation profile beyond the central optical zone to avoid an abrupt change in ablation thickness.
  • the refractive devices in FIG. 4A that induces spherical aberration or a distribution of spherical aberrations only at the central pupil of an eye can further include a periphery optical section to cover the entire pupil of an eye.
  • FIG. 4E shows a schematic diagram of such an ophthalmic device 43 front view ( 44 side view).
  • the device comprises a central optical section 45 (less than 4.5 mm in diameter) that has a radial distribution of refractive power in a range more than 4 Diopters, and an outer section 46 that has either a constant refractive power or a controlled spherical aberration beyond the central optical section.
  • the central optical section ( 47 a, 47 c, and 47 f ) has a gradually increased refractive power from the middle of the lens same as that of 41 a in FIG. 4 b .
  • the outer segment 47 b does not change spherical aberration in an eye and has a refractive power same as a baseline refractive correction.
  • the outer segment 47 d has a negative focus offset from a baseline refractive correction to optimize night vision for an eye with negative spherical aberration at pupil periphery 47 e.
  • the negative focus offset at 47 d can improve far vision at night by shifting refractive power at pupil periphery close to zero Diopter.
  • the outer segment 47 g contains spherical aberration to shift the refractive power close to zero Diopter for increased focus depth for night vision.
  • the central optical section ( 48 a, 48 c, and 48 f ) has a gradually decreased refractive power from the middle of the lens same as that of 41 b in FIG. 4 c .
  • the outer segment 48 b does not change spherical aberration in an eye and has a refractive power same as a baseline refractive correction.
  • the outer segment 48 d has a negative focus offset from a baseline refractive correction to optimize night vision for an eye with negative spherical aberration at pupil periphery 48 e.
  • the negative focus offset at 48 d will improve far vision at night by shifting refractive power at pupil periphery close to zero Diopter.
  • the outer segment 48 g contains spherical aberration to shift the refractive power close to zero Diopter for increased focus depth for night vision.
  • the central optical section has two distributions of refractive power: a zone of reduced refractive power ( 49 a, d, h ) and a zone of increased refractive power ( 49 b, e, i ) as 42 a and 42 b in FIG. 4 d .
  • the outer segment 49 c does not change spherical aberration in an eye and has a refractive power same as a baseline refractive correction.
  • FIG. 4L the outer segment 49 c does not change spherical aberration in an eye and has a refractive power same as a baseline refractive correction.
  • the outer segment 49 f has a negative focus offset from a baseline refractive correction to optimize night vision for an eye with negative spherical aberration at pupil periphery 49 g.
  • the negative focus offset at 49 f will improve far vision at night by shifting refractive power at pupil periphery close to zero Diopter.
  • the outer segment 49 j contains spherical aberration to shift the refractive power close to zero Diopter for increased focus depth for night vision.
  • the device may include tiny holes in the optic to enable proper flow of nutrients from one side of the lens to the other side.
  • the materials for making a corneal inlay may include hydrogel as well as those known in the art (see e.g., U.S. Pat. No. 5,336,261 by Graham D. Barrett, William J. Link, and Cary J. Reich). Implanting a refractive corneal inlay may be combined with a LASIK procedure for patients with conventional myopia, hyperopia, and astigmatism.
  • Lenses with induced spherical aberration in the central optic will involve in manufacturing of aspheric lenses because spherical aberration are often negligible for a small numerical aperture.
  • Aspheric lenses can be made in a number of methods known in the prior art: 1 ) by machining a lens of aspheric surface (surfaces) with a lathe tool, 2 ) by molding lenses with an aspheric mold; 3 ) by an ablation or activation process using laser beams or radiation beams.
  • the refractive correction for lenses in FIG. 4F through 4N can also be implemented for laser vision corrections by removing corneal tissues.
  • ablation profiles can easily be generated for the corrections of not only myopia, hyperopia, astigmatism, but also presbyopia.
  • Materials removed from the corneal for presbyopia needs to be equal to the t0 ⁇ W(x,y)/(n-1) where t0 is a constant thickness, W(x,y) is the spherical aberration needed for presbyopia, and n is the refractive index of corneal.
  • the refractive element may contain not only a baseline correction of myopia, hyperopia and astigmatism, but also a distributed spherical aberration in the central pupil of an eye.
  • the outer optical segment 53 is transparent to light wave and has an outer diameter of 5 mm to 7 mm for implantable lenses like Intra-Ocular Lenses (IDLs), 10 to 14 mm in diameter for contact lenses, and up to 50 mm for spectacles.
  • IDLs Intra-Ocular Lenses
  • FIG. 5B shows a schematic diagram of another refractive element 54 to be worn on or implanted in an eye for refractive correction of presbyopia.
  • the refractive element comprises at least two central aspheric segments 55 a and 55 b that create a distribution of spherical aberrations and focus offsets within a zone less than 4.5 mm in diameter, and a light attenuate section 56 outside the aspheric sections, and an outer optical segment 57 that is extended the refractive element beyond the central zones and up to 14 mm in diameter.
  • FIG. 5C shows a distribution of refractive'power with 58 a and 58 b as the two aspheric sections, light trough the shades section 58 c will be blocked or attenuated, and a zone 58 d with a constant refractive power.
  • the light attenuating section 56 ( 58 c ) can reduce or block light in an annular pupil section between ⁇ 3 mm and ⁇ 6 mm in order to reduce or eliminate impacts of high-order aberrations in individual eyes. Adding the light attenuating section can make the refractive element suitable for a variety of eyes with different high-order aberrations, and thus improve efficiency and efficacy of a refractive procedure.
  • Increasing focus depth of an eye can also be achieved by a refractive element comprising of a plurality of optical sections with a distributed focus powers and spherical aberrations across pupil of an eye.
  • FIG. 6A shows a schematic diagram of such an embodiment of a refractive element 61 to be worn on or implanted in an eye for refractive correction of presbyopia.
  • the central optical section 62 has one refractive power ⁇ c, and is an aspheric lens to create spherical aberration Cc in a small numerical aperture.
  • the diameter of the central optical section is between 1.6 mm and 4 mm.
  • the outer optical section 63 has a different refractive power ( ⁇ o from the central optical section, and a different spherical aberration Co.
  • the refractive element When the refractive element is placed in the optical path of an eye, it introduces a distributed focus powers and spherical aberrations across pupil of an eye on top of a refractive correction for myopia, hyperopia, astigmatism across pupil of an eye.
  • the outer diameter of 61 is 5 mm to 7 mm for implantable lenses like Intra-Ocular Lenses (IOLs), 1.5 mm to 6 mm for refractive corneal inlays, 10 mm to 14 mm for contact lenses, and up to 50 mm for spectacles.
  • IOLs Intra-Ocular Lenses
  • 1.5 mm to 6 mm for refractive corneal inlays 10 mm to 14 mm for contact lenses, and up to 50 mm for spectacles.
  • FIG. 6B shows a schematic diagram of an additional embodiment of a refractive element ( 64 ) to be worn on or implanted in the eye for refractive correction of presbyopia.
  • the refractive element comprises two transparent optical sections with a distributed focus powers and spherical aberrations, and a light attenuating segment between the two transparent optical sections.
  • the difference between the refractive elements in FIG. 6A and in FIG. 6B is the insertion of the light attenuating section 66 between the central aspheric section 65 and outer section 67 .
  • the light attenuating section can reduce or block light in an annular pupil section between ⁇ 3 mm and ⁇ 6 mm in order to reduce or eliminate impacts of high-order aberrations in individual eyes. Adding the light attenuating section can make the refractive element suitable for a variety of eyes with different high-order aberrations, and thus improve efficiency and efficacy of a refractive procedure.
  • Refractive corrections of presbyopia can further be achieved by mixing various design features to achieve the highest degree of tolerance.
  • the pupil periphery for night vision it is desirable to have a single dominated focus power for far vision.
  • the pupil center for outdoor vision and for day vision for eyes with small pupil it is desirable to have excellent far vision and acceptable near vision, which can be achieved by inducing spherical aberration at the central pupil.
  • the mid-pupil for indoor vision it is desirable to have excellent near vision for reading and intermediate distance, which can be achieved by a bi-focal structure.
  • Another advantage of the bi-focal structure in the mid-pupil is its insensitivity to displacement if the bi-focal lens is achieved by a structure with an alternating powers.
  • FIG. 7A and FIG. 7B shows a schematic diagram and a side view of a refractive element 71 that can be worn on or implanted into an eye for refractive correction of presbyopia according to the present invention.
  • the central portion of the lens 72 a and 72 b will have at least one aspheric surface to induce spherical aberration.
  • Three potential structures are shown with the refractive power profiles from the lens center to the radius of the central zone (R 1 ) relating to positive spherical aberration in FIG. 7C , negative spherical aberration in FIG. 7D , and a distribution of spherical aberrations in FIG. 7E .
  • the middle section of the lens 73 a and 73 b will be a bifocal lens with a refractive power of ⁇ 1 and ⁇ 2 .
  • the preferred structure for the bi-focal lens is to use alternating powers from R 1 to R 2 shown in FIG. 7C , 7 D and 7 E.
  • ⁇ 1 can be zero for a biasing to far vision or can be a positive number like 1 D for a biased vision at intermediate distance.
  • ⁇ 2 is desired to be in the range from 1 Diopter or 4 Diopters depending on individual preference.
  • the outer section of lens 74 a and 74 b will be a mono-focal lens.
  • Three structures can be designed based on the spherical aberration of an eye without the correction lens. If the eye has no spherical aberration at the pupil periphery, the outer section can be a mono-focal lens with a refractive power set for far vision. If the eye has significant spherical aberration at the pupil periphery, a bias power can be applied to the outer section for optimized for far vision at night. It is also possible to produce a lens with spherical aberration at the lens periphery to cancel out the spherical aberration at eye's pupil periphery for improved night vision.

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Mathematical Physics (AREA)
  • Eyeglasses (AREA)
  • Prostheses (AREA)

Abstract

Presbyopia in a patient's eye is treated by inducing spherical aberration in the central section of the pupil, while the peripheral section of the pupil is treated in a manner other than the central section of the pupil. For example, the peripheral section of the pupil may remain untreated, or high-order aberration may be controlled, and/or a second area of spherical aberration may be provided with different focus power.

Description

  • This application claims priority to U.S. provisional application with the Ser. No. 61/072,653 titled “Methods and devices for treatments of presbyopia” filed Apr. 2, 2008.
  • FIELD OF THE INVENTION
  • The field of the invention relates to refractive correction of human eyes, in particular, for refractive treatments of presbyopia.
  • BACKGROUND OF THE INVENTION
  • Presbyopia is an age-related problem with near vision, due to progressive reduction in the eye's ability to focus, with consequent difficulty in reading at the normal distance. An effective refractive correction of presbyopia must provide focus for far, intermediate, and near vision in all conditions of pupil size. p Diffractive intraocular lenses (IOLs) such as those described in U.S. Pat. No. 5,116,111 by Michael Simpson and John Futhey and in US 2006/0116764A1 by Michael Simpson can provide simultaneous bi-focus (far vision and near vision) correction for presbyopia, but have two inherent disadvantages: Degraded night vision with night glare caused by light scattering at the junctions of diffractive zones in the lens surface, and a blind spot at intermediate distance between the far and near focus points.
  • Multifocal designs by controlling light distribution for far, intermediate, and near vision across different aperture size of a lens were proposed by Valdmar Portney in U.S. Pat. Nos. 5,225,858 and 6,557,998B2. These lens designs can perform better for intermediate vision than Simpson's diffractive IOLs, but are also known to be inferior for performance at near vision. Moreover, Portney's lenses fail to achieve their full potential as they are based on simple geometric ray tracing, without taking into account a diffraction effect of light propagation.
  • Aspheric lenses were also proposed in U.S. Pat. No. 6,923,539B2 by Michael Simpson and in U.S. Pat. Nos. 5,166,711 and 6,409,340B1 by Valdmar Portney. These lenses have a periodic refractive power distribution across a lens. While Simpson's lens can increase focus depth for a mono-focal lens as illustrated in FIG. 9 of U.S. Pat. No. 6,923,539B2, such lens is typically not suitable for presbyopic correction.
  • Spherical aberration across the pupil of an eye produces different focusing power at different pupil radii. Negative spherical aberration across pupil of an eye was proposed for mitigation of presbyopia by Seema Somani and Kingman Yee in U.S. Pat. No. 7,261,412 B2. There, the inventors noted that negative spherical aberration across the entire pupil can shift the center of the focus range from far to an intermediate distance because negative spherical aberration produces focus power for far vision at the pupil center to intermediate vision at the pupil periphery.
  • However, inducing spherical aberration across an entire pupil of an eye has at least two limitations for presbyopic corrections. First, the total amount of spherical aberration induced across the pupil cannot be too strong to cause nighttime symptoms such as glare and starburst, which is the one of the fundamental reasons why lenses with significant spherical aberration have not been used in multifocal IDLs and contact lenses for presbyopic treatments. Second, Somani and Yee's method in U.S. Pat. No. 7,261,412 B2 is typically not sufficient for presbyoic treatments because the small amount of spherical aberration across the entire pupil only shifts the center of focus range and does not increase focus depth. Still further, currently known methods of spherical aberration for presbyopic corrections have failed to address issues of induced nighttime symptoms (glare, starburst) and increase focus depth of an eye for far vision, intermediate vision and near vision, thus rendering such solutions less than desirable.
  • Consequently, although many configurations and methods for vision correction for treatment of presbyopia are known in the art, all or almost all of them suffer from one or more disadvantages. Thus, there is still a need to provide improved configurations and methods for vision correction for treatment of presbyopia.
  • SUMMARY OF THE INVENTION
  • The present inventive subject matter is drawn to methods and devices for refractive treatment of presbyopia.
  • According to one embodiment of the invention, a corneal implant device for surgical implantation between the layers and in the optic zone of a cornea of an eye for treatment of presbyopia comprises a solid transparent optic less than 6.5 mm in diameter, wherein when implanted in the eye spherical aberration or a distribution of spherical aberrations is created in the central pupil between 1.5 mm and 4.0 mm in diameter only by the presence of said device.
  • According to another embodiment of the invention, a procedure for treatment of presbyopia comprises the steps of measuring refractive properties of an eye; removing corneal tissue to create spherical aberration or a distribution of spherical aberrations in the central pupil of an eye less than 4 mm in diameter.
  • According to another embodiment of the invention, a lens for the treatment of presbyopia of an eye comprises an inner optical section of 1.5 mm to 4 mm in diameter that contains at least one aspheric surface to induce spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power; an outer transparent optical section of 4 mm to 40 mm in diameter that is configured to have a dominant spherical focus power.
  • According to another embodiment of the invention, a lens for the treatment of presbyopia of an eye comprises an inner optical section of 1.5 mm to 3.6 mm in diameter, wherein the inner optical section contains at least one aspheric surface to create spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power; an middle optical section with an outer diameter of 2.5 mm to 5 mm that is configured to be a bi-focal lens; and an outer optical section with an outer diameter of 4 mm to 40 mm that is configured to have a dominant focus power.
  • According to another embodiment of the invention, an optical device for refractive treatment of presbyopia comprises an inner transparent optical section that contains at least one aspheric surface to induce spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power; a middle section that is configured to attenuate or block light energy; and an outer transparent optical section that is configured to have a dominant spherical focus power.
  • Various objects, features, aspects and advantages of the present invention will become more apparent from the following detailed description of preferred embodiments of the invention.
  • BRIEF DESCRIPTION OF THE DRAWING
  • FIG. 1A shows a front view of an eye's optics that is divided into two optical sections: a central optical zone and an outer optical zone.
  • FIG. 1B shows a wavefront map for a refractive correction of presbyopia in a method of introducing spherical aberration only at a central pupil section of an eye.
  • FIG. 1C shows the radial distribution of refractive power derived from the wavefront map in FIG. 1B.
  • FIG. 1D shows a wavefront map for a refractive correction of presbyopia in a method of introducing a distribution of spherical aberrations only at a central pupil section of an eye.
  • FIG. 1E shows the radial distribution of a refractive power derived from the wavefront map in FIG. 1D.
  • FIG. 2 shows the calculated MTFs (modulation transfer functions) of an eye with a wavefront map specified in FIG. 1B for three pupil sizes and at 3 different focus positions.
  • FIG. 3 shows the calculated MTFs of an eye with a wavefront map specified in FIG. 1D for three pupil sizes and at 4 different focus positions.
  • FIG. 4A shows a schematic diagram of a refractive element to be implanted into an eye for refractive corrections of presbyopia.
  • FIG. 4B shows a radial distribution of refractive power for the refractive element in FIG. 4A in one embodiment.
  • FIG. 4C shows a radial distribution of refractive power for the refractive element in FIG. 4A in another embodiment.
  • FIG. 4D shows a radial distribution of refractive power for the refractive element in FIG. 4A in yet another embodiment.
  • FIG. 4E shows schematic diagrams of a refractive element that can be worn on or implanted into an eye for refractive correction of presbyopia.
  • FIG. 4F shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a gradually increased refractive power in the central optical section and a constant refractive power beyond the central optical section.
  • FIG. 4G shows a radial distribution of refractive power for the refractive element in FIG. 4E in an embodiment that has a gradually increased refractive power in the central optical section and a custom focus offset, depending on spherical aberration in an individual eye, beyond the central optical section.
  • FIG. 4H shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a gradually increased refractive power in the central optical section and a different radial distribution of refractive power beyond the central optical section.
  • FIG. 4I shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a gradually reduced refractive power in the central optical section and a constant refractive power beyond the central optical section.
  • FIG. 4J shows a radial distribution of refractive power for the refractive element in FIG. 4E in an embodiment that has a gradually reduced refractive power in the central optical section and a custom focus offset, depending on spherical aberration in an individual eye, beyond the central optical section.
  • FIG. 4K shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a gradually reduced refractive power in the central optical section and a different radial distribution of refractive power beyond the central optical section.
  • FIG. 4L shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a first zone of reduced refractive power and a second zone of increased refractive power in the central optical section, and a constant refractive power beyond the central optical section.
  • FIG. 4M shows a radial distribution of refractive power for the refractive element in FIG. 4E in an embodiment that has a zone of reduced refractive power and a zone of increased refractive power in the central optical section, and a custom focus offset, depending on spherical aberration in an individual eye, beyond the central optical section.
  • FIG. 4N shows a radial distribution of refractive power for the refractive element in FIG. 4E in one embodiment that has a zone of reduced refractive power and another zone of increased refractive power in the central optical section, and a different radial distribution of refractive power beyond the central optical section.
  • FIG. 5A shows a schematic diagram of a refractive element to be worn on or implanted in an eye for refractive correction of presbyopia.
  • FIG. 5B shows a schematic diagram of another refractive element to be worn on or implanted in an eye for refractive correction of presbyopia.
  • FIG. 5C shows a radial distribution of refractive power for a refractive element in FIG. 5B in one embodiment.
  • FIG. 6A shows a schematic diagram of yet another refractive element to be worn on or implanted in an eye for refractive correction of presbyopia.
  • FIG. 6B shows a schematic diagram of an additional refractive element to be worn on or implanted in an eye for refractive correction of presbyopia.
  • FIG. 7A shows a schematic diagram of a refractive element that can be worn on or implanted into an eye for refractive correction of presbyopia.
  • FIG. 7B shows a side view of the refractive element in FIG. 7A that can be worn on or implanted into an eye for refractive correction of presbyopia.
  • FIG. 7C shows a radial distribution of refractive power for the refractive element in FIG. 7A in one embodiment.
  • FIG. 7D shows a radial distribution of refractive power for the refractive element in FIG. 7A in another embodiment.
  • FIG. 7E shows a radial distribution of refractive power for the refractive element in FIG. 7A in yet another embodiment.
  • DETAILED DESCRIPTION
  • Before describing wave front technologies for refractive correction of presbyopia, it must be emphasized that the refractive elements described in the present invention may include a baseline refractive correction of conventional refractive errors like myopia, hyperopia and astigmatism. For simplicity, the disclosed shapes (refractive powers and wavefront maps) only include the added wavefront map or refractive powers beyond the baseline correction for increasing focus depth from far vision to near vision.
      • I. Methods for refractive corrections of presbyopia by introducing spherical aberration or a distribution of spherical aberrations only at pupil center of an eye
  • FIG. 1A shows a schematic diagram of an eye's optics that is divided into two optical sections: the central optical section 10 less than 4.5 mm in diameter and the periphery pupil section 11 up to 8 mm in diameter. The dotted circle in FIG. 1A indicates the iris (pupil) of an eye at night. Diameter of an eye's pupil at night is different from eye to eye, and is smaller for aged eyes than for young eyes (typically 4 mm and 8 mm for night vision). For the central optical section less than 4.5 mm in diameter, it is well known that spherical aberration in normal human eyes is negligible. We describe methods for refractive correction of presbyopia by introducing positive/negative spherical aberration or a distribution of spherical aberrations only at the central pupil of an eye lens less than 4.5 mm in diameter.
  • In one embodiment, a negative (or positive) spherical aberration is introduced in the central optical section of an eye less than 4.5 mm in diameter only. An example is given in FIG. 1B, showing a wavefront map within a 6 mm zone. The wavefront shape, a negative spherical aberration of 4 microns within a diameter of 2.8 mm, can be expressed by Zernike polynomials as −0.3 (Z12(r)+3.87*Z4(r)). Beyond the central 2.8 mm zone, the wavefront is constant because no spherical aberration will be introduced.
  • FIG. 1C shows the radial distribution of refractive power derived from the wavefront map in FIG. 1B. It is seen that the introduced negative spherical aberration increases (12) the refractive power from zero Diopters from pupil center to 8.2 Diopters at radius of 1.4 mm. Beyond the central zone, the refractive power is constant (13; zero in reference to a baseline refractive power). It must be emphasized that a baseline refractive correction of myopia, hyperopia or astigmatism can be superimposed to the refractive power shown in FIG IC for eyes with conventional refractive errors.
  • In another embodiment, a distribution of spherical aberrations is introduced in a central optical section of an eye less than 4.5 mm in diameter. An example is given in FIG. 1D, showing a wavefront map within a central optical zone of 3.6 mm in diameter. Instead of a single spherical aberration across a central pupil shown in FIG. 1B, this embodiment has two sections with different distributions of spherical aberration: an inner circular section of a diameter of 1.6 mm having a positive spherical aberration and an outer annular section of a diameter of 3.6 mm having a negative spherical aberration. The circular section of 1.6 mm has a positive spherical aberration about 1.34 μm (or 0.1 (Z12(r)+3.87 Z4(r)) and also a focus offset of 4.0 Diopters. Outside the circular section, the annular section has a fixed focus power (OD) and a negative spherical aberration of about 4.3 μm (or −0.32 (Z12(r)+3.87 Z4(r)).
  • FIG. 1E shows the radial distribution of refractive power derived from the wavefront map in FIG. 1D. The positive spherical aberration in the central 1.6 mm pupil (0.8 mm in radius) causes a gradually reduced refractive power from the pupil center with a range of about 8 Diopters (14). The negative spherical aberration in an annual pupil causes a gradually increased refractive power from around 1 Diopter to around 5 Diopters (15). The wavefront map in FIG. 1D and the refractive power FIG. 1E show the central optical section with spherical aberrations only. Beyond the central 3.6 mm pupil, the wavefront as well as the refractive power is constant, which is not shown for simplicity.
  • FIG. 2 shows the calculated MTFs of a hypothetical eye with a refractive correction specified by the wavefront in FIG. 1B. Three pupil sizes (2 mm, left column; 3.5 mm, middle column; and 6 mm, right column) and 3 distances (far vision at infinity, top; intermediate vision at a focus depth of 1.0 D, middle row; and near vision at a focus depth of 2.0 D, bottom row) are considered. Three important aspects of refractive corrections are noticed. First, the induced spherical aberration in the central pupil won't significantly degrade night vision with a large pupil for distant vision (top row and right column). Second, the induced spherical aberration by the refraction element at the central pupil can extend focus depth for an eye by up to 2 Diopters for pupil size less than 3.5 mm. Third, the benefit of improved focus depth is at a cost of degraded image quality for distance vision at a small (top row and right column) and medium (top row, middle column) pupil.
  • FIG. 3 shows the calculated MTFs of a hypothetical eye with a refractive correction specified by the wavefront in FIG 1D. Since increasing spherical aberration at central pupil won't significantly degrade night vision for a large pupil for distance vision as noticed in FIG. 2, we only calculate MTFs for three pupil sizes within a central 3.6 mm pupil. Three pupil sizes (1.6 mm, left column; 2.6 mm, middle column; and 3.6 mm, right column) and 4 distances (far vision at infinity, top row; intermediate vision at a focus depth of 1.0 D, second row; near vision at a focus depth of 2.0 D, third row; and near vision at a focus depth of 3 D, bottom row) are considered. Four aspects of refractive corrections are noticed with this embodiment of inducing a distribution of spherical aberrations and focus offsets in a central pupil. First, the refractive correction provides an excellent near vision for a pupil size between 2.6 mm and 3.6 mm. Second, the refractive correction provides excellent far vision for a small pupil between 1.6 mm and 2.6 mm. Third, the total focus depth is as large as 3Diopters, which makes the embodiment suitable for all refractive correction devices, including contact lenses, spectacle lenses, IOLs, and intra-stroma refractive corneal inlay. Fourth, the benefit of improved focus depth is at a cost of degraded image quality for distance vision for a medium pupil size (top row and right column).
  • It is seen from FIG. 1A through FIG. 3 that engineering wavefront of an eye in the central pupil can achieve an increased focus depth up to 3 Diopters for pupil size within a 4 mm diameter. At night when the pupil size is larger, far vision can still be excellent if the optics in the outer pupil region beyond the central region maintains a focus at a far point (top row and right column in FIG. 2).
  • Inducing spherical aberration or a distribution of spherical aberrations in a central optical zone less than a 4.5 mm in diameter (FIG. 1B and FIG. 1D) for refractive treatments of presbyopia can be applied to a host of ophthalmic devices or procedures, including laser vision corrections, contact lenses, intraocular lenses, and refractive corneal inlays.
  • The wavefront maps in FIG. 1B and FIG. 1D can be obtained by superimposing the refractive power shown in FIG. 1C and FIG. 1E to a baseline refractive correction of myopia, hyperopia, or astigmatism, or equivalently by modifying optical path difference of a conventional lens according to a distribution of FIG. 1B and FIG. 1D.
  • For the procedure of laser vision correction (refractive correction by removing corneal tissues using laser energy), the wavefront maps in FIG. 1B and FIG. 1D can be obtained by modifying a baseline ablation profile for myopia, hyperopia, and astigmatism. The change in the ablation profile equals to t0−W(x,y)/(nc-1), where t0 is a constant thickness, W(x,y) is wavefront map (distribution), and nc is the refractive index of the cornea. Correction using a negative lens in conventional refractive correction must be implemented by removing a positive lens from a corneal for a laser vision correction.
  • For refractive corneal inlays that achieve refractive correction by altering corneal curvature, the wavefront maps like FIG. 1B and FIG. 1D can be obtained by varying thickness of an inlay according to W(x,y)/(ni-1), where W(x,y) is the desired wavefront map and ni is the refractive index of the corneal inlay. W(x,y) can include a baseline of constant phase delay.
  • For contact lenses or spectacle lenses positioned outside the cornea of an eye, the wavefront maps like FIG. 1B and FIG. 1D can be obtained by superimposing the refractive power shown in FIG. 1C and FIG. 1E to a baseline refractive correction or to a constant phase delay across a lens.
  • For intra-ocular lenses or corneal inlays that do not alter curvature of optical surface of an eye, the wavefront maps like FIG. 1B and FIG. 1D can be obtained by a variation of thickness to the baseline lenses according to W(x,y)/(nL-n0), where W(x,y) is the wavefront map and nL is the refractive index of IOLs or corneal inlay while n0 is the refractive index of cornea or the refractive index of the aqueous humor or vitreous body in the eye.
  • We have described a number of ophthalmic devices for refractive correction of presbyopia based on the methods of introducing spherical aberration or a distribution of spherical aberrations at the central pupil in an eye. Exemplary ophthalmic devices can be found in the sections hereafter.
      • (a) Refractive corneal inlays for refractive treatments of presbyopia
  • FIG. 4A shows a refractive corneal inlay for refractive correction of presbyopia in accordance with the present invention. The refractive device 40 comprises an optic of a diameter R between 1.5 mm and 4 mm, and has a radial distribution of refractive power in a range more than 4 Diopters across the optic.
  • In one embodiment as shown in FIG. 4B, the lens has the least refractive power in the middle (φ1, and a gradually increased refractive power for an increased radial distance, and a radial power range (φ21) of more than 4 Diopters and less than 12 Diopters. As an example, the lens in FIG. 4A has a diameter of 2.8 mm with a radial distribution of refractive power 41 a same as 12 in FIG. 1B, and φ1 and φ2 are 0 Diopter and 8.2 Diopters, respectively. When such a lens is implanted into the central optics of an eye, it can create a wavefront map like the one shown in FIG. 1B because the implanted lens induces a negative spherical aberration in the central optical zone and does not alter refraction of an eye beyond the lens zone. Increasing focus depth of an eye for refractive correction of presbyopia can be seen in FIG. 2 for 3 pupil sizes at 3 different focus positions.
  • In another embodiment as shown in FIG. 4C, the lens has the highest refractive power in the middle (φ1), and a gradually reduced refractive power for an increased radial distance, and a radial power range (φ21) of more than 4 Diopters and less than 12 Diopters. As an example, the lens in FIG. 4A has a diameter of 1.6 mm with a radial distribution of refractive power 41 b same as 14 in FIG. 1E, and φ1 and φ2 are 4 Diopter and −4.2 Diopters, respectively. When such a lens is implanted into the central optics of an eye, it creates a positive spherical aberration about 1 microns and a focus offset of 4 D as described in our copending International application with the Ser. No. PCT/US08/81421. Aberrations induced in the central pupil of the eye will increase focus depth of an eye by 2 to 3 Diopters for mitigation of presbyopia.
  • In yet another embodiment as shown in FIG. 4D, the lens has two radial distribution of refractive power: a first zone of reduced refractive power 42 a and a second zone of increased refractive power 42 b. As an example, the lens in FIG. 4A has a diameter of 3.6 mm with a radial distribution of refractive power 42 a same as 14 in FIG. 1E, and 42 b same as 15 in FIG. 1E. When such a lens is implanted into the central optics of an eye, it can create a wavefront map like the one shown in FIG. 1D at the central pupil and does not alter refraction of an eye beyond the lens zone. Increasing focus depth of an eye for refractive correction of presbyopia can be seen in FIG. 3 for 3 pupil sizes at 4 different focus positions.
  • In still another embodiment, a corneal inlay comprises an inner optical section of 1.5 mm to 4 mm in diameter that contains at least one aspheric surface to induce spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power, and an outer transparent optical section of up to 6 mm in diameter. The corneal inlay will have a refractive power extended across the entire corneal inlay for refractive correction of conventional myopia, hyperopia, cylinder error, and any other refractive errors in an eye.
  • It must be mentioned that the refractive correction with a corneal inlay in FIG. 4A can also be implemented with a procedure of laser vision correction. Instead of inserting a lens that is described by the refractive power in FIG. 4B through FIG. 4E, a procedure of laser vision correction will remove corneal tissues to create a radial distribution of focus power of FIG. 4C and 4E in an opposite sign, superimposed on to a baseline ablation profile for myopia, hyperopia, and astigmatism. A fixed ablation thickness can be added to the ablation profile beyond the central optical zone to avoid an abrupt change in ablation thickness.
      • (b) Ophthalmic devices to be worn on or implanted into an eye for refractive treatments of presbyopia
  • The refractive devices in FIG. 4A that induces spherical aberration or a distribution of spherical aberrations only at the central pupil of an eye can further include a periphery optical section to cover the entire pupil of an eye. FIG. 4E shows a schematic diagram of such an ophthalmic device 43 front view (44 side view). The device comprises a central optical section 45 (less than 4.5 mm in diameter) that has a radial distribution of refractive power in a range more than 4 Diopters, and an outer section 46 that has either a constant refractive power or a controlled spherical aberration beyond the central optical section.
  • In the embodiments shown in FIG. 4F through FIG. 4H, the central optical section (47 a, 47 c, and 47 f) has a gradually increased refractive power from the middle of the lens same as that of 41 a in FIG. 4 b. In one embodiment shown in FIG. 4F, the outer segment 47 b does not change spherical aberration in an eye and has a refractive power same as a baseline refractive correction. In another embodiment shown in FIG. 4G, the outer segment 47 d has a negative focus offset from a baseline refractive correction to optimize night vision for an eye with negative spherical aberration at pupil periphery 47 e. The negative focus offset at 47 d can improve far vision at night by shifting refractive power at pupil periphery close to zero Diopter. In yet another the embodiment shown in FIG. 4H, the outer segment 47 g contains spherical aberration to shift the refractive power close to zero Diopter for increased focus depth for night vision.
  • In the embodiments shown in FIG. 4I through FIG. 4K, the central optical section (48 a, 48 c, and 48 f) has a gradually decreased refractive power from the middle of the lens same as that of 41 b in FIG. 4 c. In one embodiment shown in FIG. 4I, the outer segment 48 b does not change spherical aberration in an eye and has a refractive power same as a baseline refractive correction. In another embodiment shown in FIG. 4J, the outer segment 48 d has a negative focus offset from a baseline refractive correction to optimize night vision for an eye with negative spherical aberration at pupil periphery 48 e. The negative focus offset at 48 d will improve far vision at night by shifting refractive power at pupil periphery close to zero Diopter. In yet another embodiment shown in FIG. 4K, the outer segment 48 g contains spherical aberration to shift the refractive power close to zero Diopter for increased focus depth for night vision.
  • In the embodiments shown in FIG. 4L through FIG. 4N, the central optical section has two distributions of refractive power: a zone of reduced refractive power (49 a, d, h) and a zone of increased refractive power (49 b, e, i) as 42 a and 42 b in FIG. 4 d. In the embodiment shown in FIG. 4L, the outer segment 49 c does not change spherical aberration in an eye and has a refractive power same as a baseline refractive correction. In the embodiment shown in FIG. 4M, the outer segment 49 f has a negative focus offset from a baseline refractive correction to optimize night vision for an eye with negative spherical aberration at pupil periphery 49 g. The negative focus offset at 49 f will improve far vision at night by shifting refractive power at pupil periphery close to zero Diopter. In the embodiment shown in FIG. 4N, the outer segment 49 j contains spherical aberration to shift the refractive power close to zero Diopter for increased focus depth for night vision.
  • When the devices in FIG. 4A and FIG. 4 e are used as a refractive cornea inlay implanted into the corneal stroma, the device may include tiny holes in the optic to enable proper flow of nutrients from one side of the lens to the other side. The materials for making a corneal inlay may include hydrogel as well as those known in the art (see e.g., U.S. Pat. No. 5,336,261 by Graham D. Barrett, William J. Link, and Cary J. Reich). Implanting a refractive corneal inlay may be combined with a LASIK procedure for patients with conventional myopia, hyperopia, and astigmatism.
  • Lenses with induced spherical aberration in the central optic will involve in manufacturing of aspheric lenses because spherical aberration are often negligible for a small numerical aperture. Aspheric lenses can be made in a number of methods known in the prior art: 1) by machining a lens of aspheric surface (surfaces) with a lathe tool, 2) by molding lenses with an aspheric mold; 3) by an ablation or activation process using laser beams or radiation beams.
  • It must be mentioned that the refractive correction for lenses in FIG. 4F through 4N can also be implemented for laser vision corrections by removing corneal tissues. By superimpose the distributions of refractive power to a baseline refractive correction, ablation profiles can easily be generated for the corrections of not only myopia, hyperopia, astigmatism, but also presbyopia. Materials removed from the corneal for presbyopia needs to be equal to the t0−W(x,y)/(n-1) where t0 is a constant thickness, W(x,y) is the spherical aberration needed for presbyopia, and n is the refractive index of corneal.
      • (c) Refractive correction of presbyopia by introducing a distribution of spherical aberrations and focus offsets at central pupil of an eye
  • FIG. 5A shows a schematic diagram of yet another refractive element 51 to be worn on or implanted in the eye for refractive correction of presbyopia. The refractive element comprises at least two central aspheric segments 52 a and 52 b that create a distribution of spherical aberrations and focus offsets within a zone less than 4.5 mm in diameter, and an outer optical segment 53 that extends the optic beyond the central zones and up to 50 mm in diameter.
  • It must be emphasized that the refractive element may contain not only a baseline correction of myopia, hyperopia and astigmatism, but also a distributed spherical aberration in the central pupil of an eye.
  • The central aspheric segments 52 a and 52 b comprise at least two refractive surfaces, and at least one of the two refractive surfaces in both 52 a and 52 b is aspheric to create spherical aberration in a small numerical aperture within which conventional spherical refractive surfaces will have negligible spherical aberration.
  • When placed in the optical path of an eye, the refractive element superimposes a wavefront shape like the one shown in FIG. 1D at central pupil of an eye to a baseline correction for myopia, hyperopia and astigmatism across entire pupil of an eye if necessary. As indicated in FIG. 3, the induced distribution of spherical aberrations and focus offsets can achieve a focus depth of 3 D in a pupil size within 3.6 mm without accommodation from the crystalline lens in an eye.
  • The outer optical segment 53 is transparent to light wave and has an outer diameter of 5 mm to 7 mm for implantable lenses like Intra-Ocular Lenses (IDLs), 10 to 14 mm in diameter for contact lenses, and up to 50 mm for spectacles.
  • FIG. 5B shows a schematic diagram of another refractive element 54 to be worn on or implanted in an eye for refractive correction of presbyopia. The refractive element comprises at least two central aspheric segments 55 a and 55 b that create a distribution of spherical aberrations and focus offsets within a zone less than 4.5 mm in diameter, and a light attenuate section 56 outside the aspheric sections, and an outer optical segment 57 that is extended the refractive element beyond the central zones and up to 14 mm in diameter.
  • The difference between the refractive elements in FIG. 5A and in FIG. 5B is the inclusion of the light attenuating section 56 between the central aspheric section 55 b and the outer section 57. FIG. 5C shows a distribution of refractive'power with 58 a and 58 b as the two aspheric sections, light trough the shades section 58 c will be blocked or attenuated, and a zone 58 d with a constant refractive power.
  • The light attenuating section 56 (58 c) can reduce or block light in an annular pupil section between ˜3 mm and ˜6 mm in order to reduce or eliminate impacts of high-order aberrations in individual eyes. Adding the light attenuating section can make the refractive element suitable for a variety of eyes with different high-order aberrations, and thus improve efficiency and efficacy of a refractive procedure.
      • II. Refractive correction ofpresbyopia by introducing a distribution of spherical aberrations and focus offsets across pupil of an eye
  • Increasing focus depth of an eye can also be achieved by a refractive element comprising of a plurality of optical sections with a distributed focus powers and spherical aberrations across pupil of an eye.
  • FIG. 6A shows a schematic diagram of such an embodiment of a refractive element 61 to be worn on or implanted in an eye for refractive correction of presbyopia. The central optical section 62 has one refractive power φc, and is an aspheric lens to create spherical aberration Cc in a small numerical aperture. The diameter of the central optical section is between 1.6 mm and 4 mm. The outer optical section 63 has a different refractive power (φo from the central optical section, and a different spherical aberration Co.
  • When the refractive element is placed in the optical path of an eye, it introduces a distributed focus powers and spherical aberrations across pupil of an eye on top of a refractive correction for myopia, hyperopia, astigmatism across pupil of an eye.
  • By taking into account a typical spherical aberration in a natural eye, Liang described in the copending International application with the Ser. No. PCT/US08/81421 a number of embodiments for distributed focus powers and spherical aberrations across the pupil of an eye. In one embodiment, significant negative spherical aberration is induced in the pupil center while a positive spherical aberration is induced at pupil periphery. In another embodiment, significant negative spherical aberration is induced in the pupil center while spherical aberration for a large pupil in an individual eye is eliminated. In yet another embodiment, positive spherical aberration is induced in the pupil center while spherical aberration for a large pupil of an eye is corrected. In an additional embodiment, spherical aberration is induced in the pupil center while spherical aberration in an eye is not altered by the correction devices. A special focus offset between the central section and outer section is required.
  • The outer diameter of 61 is 5 mm to 7 mm for implantable lenses like Intra-Ocular Lenses (IOLs), 1.5 mm to 6 mm for refractive corneal inlays, 10 mm to 14 mm for contact lenses, and up to 50 mm for spectacles.
  • FIG. 6B shows a schematic diagram of an additional embodiment of a refractive element (64) to be worn on or implanted in the eye for refractive correction of presbyopia. The refractive element comprises two transparent optical sections with a distributed focus powers and spherical aberrations, and a light attenuating segment between the two transparent optical sections.
  • The difference between the refractive elements in FIG. 6A and in FIG. 6B is the insertion of the light attenuating section 66 between the central aspheric section 65 and outer section 67. The light attenuating section can reduce or block light in an annular pupil section between ˜3 mm and ˜6 mm in order to reduce or eliminate impacts of high-order aberrations in individual eyes. Adding the light attenuating section can make the refractive element suitable for a variety of eyes with different high-order aberrations, and thus improve efficiency and efficacy of a refractive procedure.
      • III. Refractive correction of presbyopia by creating spherical aberration in central pupil, bifocal in mid-pupil, and mono-focal at pupil periphery.
  • Refractive corrections of presbyopia can further be achieved by mixing various design features to achieve the highest degree of tolerance. In the pupil periphery for night vision, it is desirable to have a single dominated focus power for far vision. In the pupil center for outdoor vision and for day vision for eyes with small pupil, it is desirable to have excellent far vision and acceptable near vision, which can be achieved by inducing spherical aberration at the central pupil. In the mid-pupil for indoor vision, it is desirable to have excellent near vision for reading and intermediate distance, which can be achieved by a bi-focal structure. Another advantage of the bi-focal structure in the mid-pupil is its insensitivity to displacement if the bi-focal lens is achieved by a structure with an alternating powers.
  • FIG. 7A and FIG. 7B shows a schematic diagram and a side view of a refractive element 71 that can be worn on or implanted into an eye for refractive correction of presbyopia according to the present invention. The central portion of the lens 72 a and 72 b will have at least one aspheric surface to induce spherical aberration. Three potential structures are shown with the refractive power profiles from the lens center to the radius of the central zone (R1) relating to positive spherical aberration in FIG. 7C, negative spherical aberration in FIG. 7D, and a distribution of spherical aberrations in FIG. 7E.
  • The middle section of the lens 73 a and 73 b will be a bifocal lens with a refractive power of φ1 and φ2. The preferred structure for the bi-focal lens is to use alternating powers from R1 to R2 shown in FIG. 7C, 7D and 7E. Depending on the preference of the lens design, φ1 can be zero for a biasing to far vision or can be a positive number like 1 D for a biased vision at intermediate distance. φ2 is desired to be in the range from 1 Diopter or 4 Diopters depending on individual preference.
  • The outer section of lens 74 a and 74 b will be a mono-focal lens. Three structures can be designed based on the spherical aberration of an eye without the correction lens. If the eye has no spherical aberration at the pupil periphery, the outer section can be a mono-focal lens with a refractive power set for far vision. If the eye has significant spherical aberration at the pupil periphery, a bias power can be applied to the outer section for optimized for far vision at night. It is also possible to produce a lens with spherical aberration at the lens periphery to cancel out the spherical aberration at eye's pupil periphery for improved night vision.
  • Further devices, methods, and contemplations are provided in our co-pending PCT application with the Ser. No. PCT/US08/81421 titled “Methods and devices for Refractive treatments of presbyopia”, which was filed Oct. 28, 2008, and which is incorporated by reference herein.
  • Thus, specific embodiments and applications of treatment of presbyopia have been disclosed. It should be apparent, however, to those skilled in the art that many more modifications besides those already described are possible without departing from the inventive concepts herein. The inventive subject matter, therefore, is not to be restricted except in the spirit of the appended claims. Moreover, in interpreting both the specification and the claims, all terms should be interpreted in the broadest possible manner consistent with the context. In particular, the terms “comprises” and “comprising” should be interpreted as referring to elements, components, or steps in a non-exclusive manner, indicating that the referenced elements, components, or steps may be present, or utilized, or combined with other elements, components, or steps that are not expressly referenced.

Claims (26)

1. A corneal implant device for surgical implantation between layers and in an optic zone of a cornea of an eye for treatment of presbyopia, comprising a solid transparent optic having a diameter of equal or less than 6.5 mm, wherein the device is configured such that, when implanted in the eye, spherical aberration or a distribution of spherical aberrations is created in a central area of a pupil, wherein the central area of the pupil has a diameter of between 1.5 mm and 4.0 mm, and wherein the spherical aberration or the distribution of spherical aberrations is created only by the presence of said device.
2. The device of claim 1, wherein said device is configured to have a circular shape with a radial distance expressed by r, and wherein the device is further configured to have a thickness profile in a central portion that is expressed at least in part by r4 to so allow creation of the spherical aberration or a distribution of spherical aberrations.
3. The device of claim 1, wherein the device is configured such that the spherical aberration or the distribution of spherical aberrations allows production of a focus variation selected from the group consisting of (a) setting a far point at a center of the device and having a radially increased refractive power, (b) having a radially decreased refractive power and setting a portion of the eye for hyperopia, and (c) having at least one zone with a radially increased refractive power another zone with a radially decreased refractive power and setting a portion of the eye for hyperopia.
4. The device of claim 1, wherein the device is configured such that the spherical aberration or the distribution of spherical aberrations can produce a focus variation of more than 4 diopters.
5. The device of claim 1, wherein the device is made of biocompatible materials suitable for corneal implantation.
6. The device of claim 1, wherein the device is further configured to have refractive powers for correction of at least one of focus error, astigmatism, and coma in the eye.
7. A method of treating presbyopia, comprising:
(a) measuring refractive properties of an eye; and
(b) removing corneal tissue to create a spherical aberration or a distribution of spherical aberrations in a central portion of a pupil of an eye, wherein the central portion is equal or less than 4 mm in diameter.
8. The method of claim 7, wherein the spherical aberration or the distribution of spherical aberrations produces a focus variation selected from the group consisting of (a) setting a far point at a center of the pupil and having a radially increased refractive power, (b) having a radially decreased refractive power and setting a portion of the eye for hyperopia, and (c) having at least one zone with a radially increased refractive power and another zone with a radially decreased refractive power and setting a portion of the eye for hyperopia.
9. The method of claim 7, wherein spherical aberration or a distribution of spherical aberrations produces a focus variation more than 4 diopters.
10. The method of claim 7, further comprising a step of removing corneal tissue for additional refractive correction of at least one of myopia, hyperopia, and cylindrical error in the eye.
11. The method of claim 10, wherein the step of removing corneal tissue is achieved by applying photon energy to the corneal tissue.
12. A lens for the treatment of presbyopia of an eye, comprising:
an inner optical section of 1.5 mm to 3.6 mm in diameter, wherein the inner optical section comprises at least one aspheric surface, wherein the aspheric surface is configured to allow creation of a spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power;
a middle optical section having an outer diameter of 2.5 mm to 5 mm, wherein the middle optical section is configured as a bi-focal lens; and
an outer optical section having an outer diameter of 4 mm to 40 mm, wherein the outer optical section is configured to have a dominant focus power.
13. The lens of claim 12, wherein the spherical aberration or the distribution of spherical aberrations allows production of a focus variation selected from the group consisting of (a) setting a far point at a center of the lens and having a radially increased refractive power, (b) having a radially decreased refractive power and setting a portion of the eye for hyperopia, and (c) having at least one zone with a radially increased refractive power another zone with a radially decreased refractive power and setting a portion of the eye for hyperopia.
14. The lens of claim 12, wherein the lens is configured such that the spherical aberration or the distribution of spherical aberrations allows production of a focus variation of more than 4 diopters.
15. The lens of claim 12, wherein the lens is configured as an implantable lens or a wearable lens.
16. The lens of claim 12 wherein the lens is further configured to allow production of a cylindrical refractive power.
17. An optical device for refractive treatment of presbyopia comprising:
an inner transparent optical section that comprises at least one aspheric surface that is configured to allow induction of a spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power;
a middle section that is configured to allow attenuation or blocking of light energy; and
an outer transparent optical section that is configured to provide at least a spherical focus power for far vision at night.
18. The device of claim 17, wherein the device is configured such that the spherical aberration or the distribution of spherical aberrations allows production of a focus variation selected from the group consisting of (a) setting a far point at a center of the device and having a radially increased refractive power, (b) having a radially decreased refractive power and setting a portion of the eye for hyperopia, and (c) having at least one zone with a radially increased refractive power another zone with a radially decreased refractive power and setting a portion of the eye for hyperopia.
19. The device of claim 17, wherein the device is configured such that the spherical aberration or the distribution of spherical aberrations allows production of a focus variation of more than 4 diopters.
20. The device of claim 17, wherein the inner transparent optical section has a diameter of between 1.5 mm and 3.6 mm.
21. The device of claim 17, wherein an outer diameter of the middle section is between 2.5 mm and 5 mm.
22. The device of claim 17, wherein an outer diameter of the outer transparent optical section is between 4 mm and 40 mm.
23. The device of claim 17, wherein the device is configured to produce a cylindrical refractive power.
24. The device of claim 17, wherein the device is configured as an implantable lens or a wearable lens.
25. A lens for the treatment of presbyopia of an eye comprising:
an inner optical section having a diameter of 1.5 mm to 4 mm and comprising at least one aspheric surface that is configured to allow induction of a spherical aberration or a distribution of spherical aberrations in addition to a spherical focus power; and
an outer transparent optical section having a diameter of 4 mm to 40 mm, wherein the outer transparent optical section is configured to have at least a spherical focus power for far vision at night.
26. The lens of claim 25, wherein the lens is configured such that the spherical aberration or the distribution of spherical aberrations allows production of a focus variation for more than 4 diopters in a manner selected from the group consisting of (a) setting a far point at a center of the lens and having a radially increased refractive power, (b) having a radially decreased refractive power and setting a portion of the eye for hyperopia, and (c) having at least one zone with a radially increased refractive power another zone with a radially decreased refractive power and setting a portion of the eye for hyperopia.
US12/935,287 2008-04-02 2009-03-31 Methods and Devices for Refractive Corrections of Presbyopia Abandoned US20110029073A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/935,287 US20110029073A1 (en) 2008-04-02 2009-03-31 Methods and Devices for Refractive Corrections of Presbyopia

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7265308P 2008-04-02 2008-04-02
PCT/US2009/001980 WO2009123700A2 (en) 2008-04-02 2009-03-31 Methods and devices for refractive corrections of presbyopia
US12/935,287 US20110029073A1 (en) 2008-04-02 2009-03-31 Methods and Devices for Refractive Corrections of Presbyopia

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/001980 A-371-Of-International WO2009123700A2 (en) 2008-04-02 2009-03-31 Methods and devices for refractive corrections of presbyopia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/862,188 Division US11529228B2 (en) 2008-04-02 2020-04-29 Methods and devices for refractive corrections of presbyopia

Publications (1)

Publication Number Publication Date
US20110029073A1 true US20110029073A1 (en) 2011-02-03

Family

ID=41136053

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/935,287 Abandoned US20110029073A1 (en) 2008-04-02 2009-03-31 Methods and Devices for Refractive Corrections of Presbyopia
US16/862,188 Active 2029-06-12 US11529228B2 (en) 2008-04-02 2020-04-29 Methods and devices for refractive corrections of presbyopia
US18/051,842 Pending US20230083510A1 (en) 2008-04-02 2022-11-01 Methods And Devices For Refractive Corrections Of Presbyopia

Family Applications After (2)

Application Number Title Priority Date Filing Date
US16/862,188 Active 2029-06-12 US11529228B2 (en) 2008-04-02 2020-04-29 Methods and devices for refractive corrections of presbyopia
US18/051,842 Pending US20230083510A1 (en) 2008-04-02 2022-11-01 Methods And Devices For Refractive Corrections Of Presbyopia

Country Status (5)

Country Link
US (3) US20110029073A1 (en)
EP (2) EP3120808A1 (en)
ES (1) ES2609289T3 (en)
MX (1) MX345877B (en)
WO (1) WO2009123700A2 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150029460A1 (en) * 2009-09-01 2015-01-29 Arthur Bradley Multifocal correction providing improved quality of vision
US20150185500A1 (en) * 2013-12-31 2015-07-02 Patrick C. Ho Displayed Image-Optimized Lens
US20150250652A1 (en) * 2008-04-04 2015-09-10 Keith Holliday Methods of correcting vision
US9195074B2 (en) 2012-04-05 2015-11-24 Brien Holden Vision Institute Lenses, devices and methods for ocular refractive error
US9201250B2 (en) 2012-10-17 2015-12-01 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
US9541773B2 (en) 2012-10-17 2017-01-10 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
US9549848B2 (en) 2007-03-28 2017-01-24 Revision Optics, Inc. Corneal implant inserters and methods of use
US9877823B2 (en) 2007-03-28 2018-01-30 Revision Optics, Inc. Corneal implant retaining devices and methods of use
US9889000B2 (en) 2000-09-12 2018-02-13 Revision Optics, Inc. Corneal implant applicators
US9987124B2 (en) 2011-10-21 2018-06-05 Revision Optics, Inc. Corneal implant storage and delivery devices
US10092393B2 (en) 2013-03-14 2018-10-09 Allotex, Inc. Corneal implant systems and methods
CN109124825A (en) * 2018-07-16 2019-01-04 武汉科技大学 A kind of personalized cornea implant based on transparent polyurethane
WO2019169372A1 (en) * 2018-03-02 2019-09-06 Lensar, Inc. Laser methods and systems for addressing, mitigating and reversing presbyopia
US10449090B2 (en) 2015-07-31 2019-10-22 Allotex, Inc. Corneal implant systems and methods
US10555805B2 (en) 2006-02-24 2020-02-11 Rvo 2.0, Inc. Anterior corneal shapes and methods of providing the shapes
US10583041B2 (en) 2015-03-12 2020-03-10 RVO 2.0 Inc. Methods of correcting vision
US10792147B2 (en) * 2018-08-09 2020-10-06 Nikon Corporation Ophthalmic lens and method of manufacturing ophthalmic lens
US10835371B2 (en) 2004-04-30 2020-11-17 Rvo 2.0, Inc. Small diameter corneal inlay methods
WO2020236330A1 (en) 2019-05-20 2020-11-26 Junzhong Liang Methods and devices for wavefront treatments of astigmatism, coma, presbyopia in human eyes
WO2021236236A1 (en) * 2020-05-22 2021-11-25 Innovega Inc. Article of manufacture including an occlusion ring and related methods
US11300812B2 (en) * 2017-07-07 2022-04-12 Largan Medical Co., Ltd. Contact lens and product thereof
US20220206320A1 (en) * 2019-04-25 2022-06-30 Bei QI Optical frame glasses
EP3241063B1 (en) * 2014-12-29 2023-12-27 BF Research S.r.L. Contact lens and method for the production of a contact lens
US12130504B2 (en) * 2019-04-25 2024-10-29 Bei QI Optical frame glasses

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101909539B (en) 2007-10-29 2014-04-16 梁俊忠 Methods for improving lens focus range and multi-focus lens
US9277863B2 (en) 2008-12-01 2016-03-08 Perfect Vision Technology (Hk) Ltd. Methods and systems for automated measurement of the eyes and delivering of sunglasses and eyeglasses
US9649032B2 (en) 2008-12-01 2017-05-16 Perfect Vision Technology (Hk) Ltd. Systems and methods for remote measurement of the eyes and delivering of sunglasses and eyeglasses
EP2347740A1 (en) * 2010-01-25 2011-07-27 Technolas Perfect Vision GmbH System and method for performing a presbyopic correction
RU2661059C2 (en) * 2013-07-08 2018-07-11 Уэйвлайт Гмбх Method of treating presbyopia
US10444539B2 (en) 2016-05-11 2019-10-15 Perect Vision Technology (Hk) Ltd. Methods and systems for determining refractive corrections of human eyes for eyeglasses
CN110262070A (en) * 2019-04-19 2019-09-20 上海基诺光学有限公司 A kind of personalized optical mirror slip and its design method for nighttime driving
US20220192883A1 (en) * 2020-12-19 2022-06-23 Alcon Inc. Ablation systems and methods for treating presbyopia

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795462A (en) * 1987-08-24 1989-01-03 Grendahl Dennis T Cylindrically segmented zone of focus artificial lens
US5089024A (en) * 1988-04-19 1992-02-18 Storz Instrument Company Multi-focal intraocular lens
US6082856A (en) * 1998-11-09 2000-07-04 Polyvue Technologies, Inc. Methods for designing and making contact lenses having aberration control and contact lenses made thereby
US20030199858A1 (en) * 2002-04-18 2003-10-23 Schelonka Lee Paul Multifocal refractive surgery optimized to pupil dimensions and visual acuity requirements
US20050041203A1 (en) * 2003-08-20 2005-02-24 Lindacher Joseph Michael Ophthalmic lens with optimal power profile
US20050246015A1 (en) * 2004-04-30 2005-11-03 Troy Miller Aspherical corneal implant
US20060238702A1 (en) * 1999-04-30 2006-10-26 Advanced Medical Optics, Inc. Ophthalmic lens combinations
US7261412B2 (en) * 2005-06-30 2007-08-28 Visx, Incorporated Presbyopia correction through negative high-order spherical aberration

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504982A (en) * 1982-08-05 1985-03-19 Optical Radiation Corporation Aspheric intraocular lens
US5270744A (en) 1987-06-01 1993-12-14 Valdemar Portney Multifocal ophthalmic lens
US5166711A (en) 1987-06-01 1992-11-24 Valdemar Portney Multifocal ophthalmic lens
US5225858A (en) 1987-06-01 1993-07-06 Valdemar Portney Multifocal ophthalmic lens
US5116111A (en) 1988-04-01 1992-05-26 Minnesota Mining And Manufacturing Company Multi-focal diffractive ophthalmic lenses
US5089204A (en) 1990-03-16 1992-02-18 Nkk Corporation Method of extruding thermoplastic resin pipe
US5147393A (en) 1991-04-05 1992-09-15 Alcon Surgical, Inc. Bifocal intraocular lens with correction for spherical abberation
US5196026A (en) 1991-09-16 1993-03-23 Chiron Ophthalmics, Inc. Method of implanting corneal inlay lenses smaller than the optic zone
US5384606A (en) * 1992-06-22 1995-01-24 Allergan, Inc. Diffractive/refractive spectacle and intraocular lens system for age-related macular degeneration
US5619289A (en) * 1993-03-31 1997-04-08 Permeable Technologies, Inc. Multifocal contact lens
US5652638A (en) * 1995-05-04 1997-07-29 Johnson & Johnson Vision Products, Inc. Concentric annular ring lens designs for astigmatism
US6210005B1 (en) 1999-02-04 2001-04-03 Valdemar Portney Multifocal ophthalmic lens with reduced halo size
MXPA05002669A (en) * 2002-09-13 2005-08-19 Ocular Sciences Inc Devices and methods for improving vision.
US7036931B2 (en) * 2003-01-29 2006-05-02 Novartis Ag Ophthalmic lenses
US20050043794A1 (en) * 2003-03-31 2005-02-24 Edward Geraghty Aspheric intraocular lens
US6923539B2 (en) 2003-05-12 2005-08-02 Alcon, Inc. Aspheric lenses
US20060116764A1 (en) 2004-12-01 2006-06-01 Simpson Michael J Apodized aspheric diffractive lenses
US20060116763A1 (en) * 2004-12-01 2006-06-01 Simpson Michael J Contrast-enhancing aspheric intraocular lens
US20070129797A1 (en) * 2005-12-01 2007-06-07 Revision Optics, Inc. Intracorneal inlays
JP5041739B2 (en) 2006-06-14 2012-10-03 Hoya株式会社 Intraocular lens
CN101909539B (en) 2007-10-29 2014-04-16 梁俊忠 Methods for improving lens focus range and multi-focus lens

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795462A (en) * 1987-08-24 1989-01-03 Grendahl Dennis T Cylindrically segmented zone of focus artificial lens
US5089024A (en) * 1988-04-19 1992-02-18 Storz Instrument Company Multi-focal intraocular lens
US6082856A (en) * 1998-11-09 2000-07-04 Polyvue Technologies, Inc. Methods for designing and making contact lenses having aberration control and contact lenses made thereby
US20060238702A1 (en) * 1999-04-30 2006-10-26 Advanced Medical Optics, Inc. Ophthalmic lens combinations
US20030199858A1 (en) * 2002-04-18 2003-10-23 Schelonka Lee Paul Multifocal refractive surgery optimized to pupil dimensions and visual acuity requirements
US20050041203A1 (en) * 2003-08-20 2005-02-24 Lindacher Joseph Michael Ophthalmic lens with optimal power profile
US20050246015A1 (en) * 2004-04-30 2005-11-03 Troy Miller Aspherical corneal implant
US7261412B2 (en) * 2005-06-30 2007-08-28 Visx, Incorporated Presbyopia correction through negative high-order spherical aberration

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9889000B2 (en) 2000-09-12 2018-02-13 Revision Optics, Inc. Corneal implant applicators
US10835371B2 (en) 2004-04-30 2020-11-17 Rvo 2.0, Inc. Small diameter corneal inlay methods
US10555805B2 (en) 2006-02-24 2020-02-11 Rvo 2.0, Inc. Anterior corneal shapes and methods of providing the shapes
US9877823B2 (en) 2007-03-28 2018-01-30 Revision Optics, Inc. Corneal implant retaining devices and methods of use
US9549848B2 (en) 2007-03-28 2017-01-24 Revision Optics, Inc. Corneal implant inserters and methods of use
US20150250652A1 (en) * 2008-04-04 2015-09-10 Keith Holliday Methods of correcting vision
US9539143B2 (en) * 2008-04-04 2017-01-10 Revision Optics, Inc. Methods of correcting vision
US9770326B2 (en) * 2009-09-01 2017-09-26 Arthur Bradley Multifocal correction providing improved quality of vision
US20150029460A1 (en) * 2009-09-01 2015-01-29 Arthur Bradley Multifocal correction providing improved quality of vision
JP2016190078A (en) * 2009-09-01 2016-11-10 ブラッドリー アーサー Multifocal correction providing improved quality of vision
US9987124B2 (en) 2011-10-21 2018-06-05 Revision Optics, Inc. Corneal implant storage and delivery devices
US10948743B2 (en) 2012-04-05 2021-03-16 Brien Holden Vision Institute Limited Lenses, devices, methods and systems for refractive error
US9575334B2 (en) 2012-04-05 2017-02-21 Brien Holden Vision Institute Lenses, devices and methods of ocular refractive error
US9535263B2 (en) 2012-04-05 2017-01-03 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
US10466507B2 (en) 2012-04-05 2019-11-05 Brien Holden Vision Institute Limited Lenses, devices and methods for ocular refractive error
US11644688B2 (en) 2012-04-05 2023-05-09 Brien Holden Vision Institute Limited Lenses, devices and methods for ocular refractive error
US10838235B2 (en) 2012-04-05 2020-11-17 Brien Holden Vision Institute Limited Lenses, devices, and methods for ocular refractive error
US10203522B2 (en) 2012-04-05 2019-02-12 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
US10209535B2 (en) 2012-04-05 2019-02-19 Brien Holden Vision Institute Lenses, devices and methods for ocular refractive error
US9195074B2 (en) 2012-04-05 2015-11-24 Brien Holden Vision Institute Lenses, devices and methods for ocular refractive error
US11809024B2 (en) 2012-04-05 2023-11-07 Brien Holden Vision Institute Limited Lenses, devices, methods and systems for refractive error
US11320672B2 (en) 2012-10-07 2022-05-03 Brien Holden Vision Institute Limited Lenses, devices, systems and methods for refractive error
US10520754B2 (en) 2012-10-17 2019-12-31 Brien Holden Vision Institute Limited Lenses, devices, systems and methods for refractive error
US9201250B2 (en) 2012-10-17 2015-12-01 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
US10534198B2 (en) 2012-10-17 2020-01-14 Brien Holden Vision Institute Limited Lenses, devices, methods and systems for refractive error
US11333903B2 (en) 2012-10-17 2022-05-17 Brien Holden Vision Institute Limited Lenses, devices, methods and systems for refractive error
US9541773B2 (en) 2012-10-17 2017-01-10 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
US9759930B2 (en) 2012-10-17 2017-09-12 Brien Holden Vision Institute Lenses, devices, systems and methods for refractive error
US10092393B2 (en) 2013-03-14 2018-10-09 Allotex, Inc. Corneal implant systems and methods
US20150185500A1 (en) * 2013-12-31 2015-07-02 Patrick C. Ho Displayed Image-Optimized Lens
US10394053B2 (en) * 2013-12-31 2019-08-27 Patrick C Ho Displayed image-optimized lens
EP3241063B1 (en) * 2014-12-29 2023-12-27 BF Research S.r.L. Contact lens and method for the production of a contact lens
US10583041B2 (en) 2015-03-12 2020-03-10 RVO 2.0 Inc. Methods of correcting vision
US10952900B2 (en) 2015-07-31 2021-03-23 Allotex, Inc. Corneal implant systems and methods
US12070422B2 (en) 2015-07-31 2024-08-27 Allotex, Inc. Corneal implant systems and methods
US10449090B2 (en) 2015-07-31 2019-10-22 Allotex, Inc. Corneal implant systems and methods
US11867985B2 (en) 2017-06-23 2024-01-09 Largan Medical Co., Ltd. Contact lens and product thereof
US11300812B2 (en) * 2017-07-07 2022-04-12 Largan Medical Co., Ltd. Contact lens and product thereof
WO2019169372A1 (en) * 2018-03-02 2019-09-06 Lensar, Inc. Laser methods and systems for addressing, mitigating and reversing presbyopia
CN109124825A (en) * 2018-07-16 2019-01-04 武汉科技大学 A kind of personalized cornea implant based on transparent polyurethane
US10792147B2 (en) * 2018-08-09 2020-10-06 Nikon Corporation Ophthalmic lens and method of manufacturing ophthalmic lens
US12130504B2 (en) * 2019-04-25 2024-10-29 Bei QI Optical frame glasses
US20220206320A1 (en) * 2019-04-25 2022-06-30 Bei QI Optical frame glasses
CN114127621A (en) * 2019-05-20 2022-03-01 梁俊忠 Wavefront treatment method and device for astigmatism, coma and presbyopia of human eyes
EP3973353A4 (en) * 2019-05-20 2023-02-08 Junzhong Liang Methods and devices for wavefront treatments of astigmatism, coma, presbyopia in human eyes
JP2022539295A (en) * 2019-05-20 2022-09-08 リアン,ジュンジョン Methods and apparatus for wavefront treatment of astigmatism, coma and presbyopia in human eyes
WO2020236330A1 (en) 2019-05-20 2020-11-26 Junzhong Liang Methods and devices for wavefront treatments of astigmatism, coma, presbyopia in human eyes
US11723763B2 (en) 2020-05-22 2023-08-15 Innovega Inc. Article of manufacture including occlusion ring having inner/outer regions with orthogonal polarizations
WO2021236236A1 (en) * 2020-05-22 2021-11-25 Innovega Inc. Article of manufacture including an occlusion ring and related methods
EP4154056A4 (en) * 2020-05-22 2024-09-25 Innovega Inc Article of manufacture including an occlusion ring and related methods

Also Published As

Publication number Publication date
WO2009123700A2 (en) 2009-10-08
MX345877B (en) 2017-02-21
MX2010010714A (en) 2010-11-09
EP2265216A2 (en) 2010-12-29
WO2009123700A3 (en) 2009-12-23
EP2265216A4 (en) 2015-07-29
ES2609289T3 (en) 2017-04-19
EP2265216B1 (en) 2016-10-12
US20230083510A1 (en) 2023-03-16
US20200253719A1 (en) 2020-08-13
US11529228B2 (en) 2022-12-20
EP3120808A1 (en) 2017-01-25

Similar Documents

Publication Publication Date Title
US11529228B2 (en) Methods and devices for refractive corrections of presbyopia
US8529559B2 (en) Methods and devices for refractive treatments of presbyopia
AU2017202382B2 (en) Asymmetric lens design and method for preventing and/or slowing myopia progression
AU2017201819B2 (en) Multifocal lens design and method for preventing and/or slowing myopia progression
JP6953115B2 (en) Contact lenses with non-coaxial small lenses to prevent and / or slow the progression of myopia
US20240000561A1 (en) Full depth of focus intraocular lens
KR101701767B1 (en) Multifocal correction providing improved quality of vision
CA2643286C (en) Small diameter inlays
TW201940135A (en) Ophthalmic lens with an optically non-coaxial zone for myopia control
KR20190136952A (en) Ophthalmic lens comprising lenslets for preventing and/or slowing myopia progression
WO2011065986A1 (en) Adjustable multifocal intraocular lens system
CN113194893A (en) Intraocular lens with extended depth of focus
US11547554B2 (en) High definition and extended depth of field intraocular lens
US20210378508A1 (en) Methods and Systems for Determining Wavefronts for Forming Optical Structures in Ophthalmic Lenses
AU2012201316B2 (en) Small diameter inlays

Legal Events

Date Code Title Description
STCV Information on status: appeal procedure

Free format text: ON APPEAL -- AWAITING DECISION BY THE BOARD OF APPEALS

STCV Information on status: appeal procedure

Free format text: BOARD OF APPEALS DECISION RENDERED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION

AS Assignment

Owner name: SIFI S.P.A., ITALY

Free format text: LICENSE;ASSIGNOR:LIANG, JUNZHONG;REEL/FRAME:064516/0364

Effective date: 20180101